CN Patent

CN112409331A — 杂环类衍生物抑制剂、其制备方法和应用

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2021-02-26 · 5y expired

What this patent protects

本发明涉及杂环类衍生物抑制剂、其制备方法和应用。特别地，本发明涉及通式(I)所示的化合物、其制备方法及含有该化合物的药物组合物，及其作为P2X3抑制剂在治疗P2X3受体功能障碍疾病中的用途，特别是在治疗神经源性疾病的用途。

USPTO Abstract

本发明涉及杂环类衍生物抑制剂、其制备方法和应用。特别地，本发明涉及通式(I)所示的化合物、其制备方法及含有该化合物的药物组合物，及其作为P2X3抑制剂在治疗P2X3受体功能障碍疾病中的用途，特别是在治疗神经源性疾病的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN112409331A
Jurisdiction
CN
Classification
—
Expires
2021-02-26
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.